Thursday, April 16, 2026
  • About Web3Wire
  • Web3Wire NFTs
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Media Network
  • RSS Feed
  • Contact Us
Web3Wire
No Result
View All Result
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
No Result
View All Result
Web3Wire
No Result
View All Result
Home Press Release GlobeNewswire

Audizen Drops Officially Launched: Natural Tinnitus Support Inspired by Audifort

August 3, 2025
in GlobeNewswire, Web3
Reading Time: 11 mins read
5
SHARES
246
VIEWS
Share on TwitterShare on LinkedInShare on Facebook

New York City, NY, Aug. 02, 2025 (GLOBE NEWSWIRE) —

Audizen Drops’ Official Launch: A Science-Backed Solution for Sciatic Nerve Discomfort – Audizen for Neuropathy

In 2025, a new contender has emerged in the realm of nerve health supplements: Audizen Drops, a liquid dietary supplement designed to address sciatic nerve discomfort. As the prevalence of sciatica and related neuropathic conditions rises, driven by factors like sedentary lifestyles and aging populations, Audizen Drops aims to provide a natural, science-informed approach to managing nerve pain. This article explores the official launch of Audizen Drops, its formulation, the science behind its ingredients, and its place in the evolving landscape of nerve health support, presented in a neutral and informative manner.

Explore Audizen – Inspired by Audifort, Now Available in US, UK, Canada & Australia

Understanding Sciatic Nerve Discomfort

The sciatic nerve, the body’s largest nerve, extends from the lower back through the hips, buttocks, and down each leg. When compressed or irritated, it can cause sciatica, a condition marked by sharp, radiating pain, numbness, tingling, or burning sensations along its path. Sciatica can stem from herniated discs, spinal stenosis, muscle imbalances, or prolonged sitting, with symptoms ranging from mild discomfort to severe, mobility-limiting pain. For many, sciatica disrupts daily activities, sleep, and overall well-being, prompting a search for effective, non-invasive solutions.

Traditional treatments, such as pain relievers, physical therapy, or corticosteroid injections, often focus on symptom relief but may not address underlying factors like inflammation or nerve sensitivity. This has fueled demand for natural supplements like Audizen Drops, which aim to support nerve health and reduce discomfort through a holistic approach.

The Official Launch of Audizen Drops

Audizen Drops, developed by Audizen Labs in the United States, was officially launched in 2025 as a liquid supplement tailored for sciatic nerve discomfort and neuropathy. Unlike conventional oral painkillers, Audizen Drops utilizes a sublingual delivery method—administered under the tongue—for faster absorption and bioavailability. The product is manufactured in FDA-registered, GMP-certified facilities, emphasizing purity, safety, and quality control. Audizen Labs positions the drops as a non-GMO, plant-based solution free of artificial additives, targeting health-conscious consumers seeking alternatives to pharmaceuticals.

The launch of Audizen Drops is rooted in the vision of its lead formulator, Dr. Sarah Mitchell, a neurologist inspired by her patients’ struggles with chronic nerve pain. The supplement is designed to address what Audizen Labs calls the “neuropathy triad”: inflammation reduction, nerve function support, and pain signal modulation. Available exclusively through the official Audizen website, the product comes with a 60-day money-back guarantee, reflecting the brand’s confidence in its efficacy.

Key Ingredients and Their Roles

Audizen Drops combines a blend of natural ingredients with scientific backing for nerve health and inflammation management. Below is an overview of its primary components and their purported benefits:

  • Ginkgo Biloba Extract
    Ginkgo biloba is renowned for improving blood circulation, particularly to peripheral nerves. Enhanced blood flow delivers oxygen and nutrients to the sciatic nerve, potentially reducing discomfort caused by poor circulation. Studies, such as those in Journal of Clinical Pharmacology (2019), suggest ginkgo biloba may alleviate neuropathic pain by supporting microcirculation and reducing oxidative stress.
  • Magnesium (as Magnesium Citrate)
    Magnesium is critical for nerve function and muscle relaxation. It modulates NMDA receptors, which play a role in pain signaling. A 2021 study from the University of Maryland found that magnesium supplementation reduced neuropathic pain intensity by up to 38% in some patients. Magnesium citrate, used in Audizen Drops, is highly bioavailable, supporting nerve signal regulation and muscle comfort.
  • Vitamin B12 (Methylcobalamin)
    Vitamin B12 is essential for nerve repair and maintaining the myelin sheath, which insulates nerve fibers. Deficiencies are linked to worsened neuropathy symptoms, including tingling and numbness. Research in Neurology (2020) indicates B12 supplementation can improve nerve function in neuropathic conditions, making it a key component for sciatica support.
  • Hibiscus Extract
    Hibiscus is traditionally used for its anti-inflammatory properties. By reducing inflammation around the sciatic nerve, it may alleviate pressure and pain. While less studied for neuropathy specifically, hibiscus’s antioxidant effects, noted in Phytotherapy Research (2018), suggest potential benefits for reducing nerve-related inflammation.
  • Alpha-Lipoic Acid (ALA)
    ALA is a powerful antioxidant that protects nerve cells from oxidative damage, a contributor to neuropathy. Clinical trials, such as those in Diabetes Care (2018), have shown ALA reduces burning and numbness in diabetic neuropathy, suggesting applicability for sciatica. Its ability to regenerate other antioxidants enhances its protective effects.
  • Hawthorn Berry Extract
    Hawthorn supports cardiovascular health and circulation, ensuring nerves receive adequate blood flow. Its antioxidant properties, documented in Journal of Herbal Medicine (2020), may also reduce inflammation, supporting nerve health indirectly.
  • Gymnema Sylvestre
    This herb is known for its anti-inflammatory and nerve-soothing properties. Preliminary studies, such as those in Journal of Ethnopharmacology (2017), suggest it may calm overactive nerve signals, reducing sensations like tingling or burning in neuropathic conditions.
  • Neurocalm Blend
    Audizen’s proprietary Neurocalm Blend is described as a combination of adaptogenic herbs and nerve-supporting nutrients. While specifics are not fully disclosed, it likely enhances the formula’s calming and anti-inflammatory effects, targeting nerve hypersensitivity.

How Audizen Drops Work?

Audizen Drops employs a multi-pronged approach to address sciatic nerve discomfort:

  • Reducing Inflammation: Hibiscus, hawthorn, and ALA target inflammation, a key driver of sciatic pain, by neutralizing free radicals and calming immune responses.
  • Supporting Nerve Function: Vitamin B12, magnesium, and ginkgo biloba nourish nerve cells, promote repair, and enhance signal transmission.
  • Improving Circulation: Ginkgo biloba and hawthorn ensure optimal blood flow to the sciatic nerve, reducing discomfort caused by nutrient deficiencies.
  • Modulating Pain Signals: Gymnema sylvestre and the Neurocalm Blend soothe overactive nerves, reducing sensations like burning or tingling.

The sublingual delivery method allows ingredients to bypass the digestive system, entering the bloodstream directly for faster effects. Users are advised to take 2–6 drops daily under the tongue, preferably with a meal, for consistent results. Some report noticing improvements within weeks, though Audizen Labs recommends 60–90 days of use for optimal benefits.

The Science Behind Audizen Drops

The ingredients in Audizen Drops are supported by varying degrees of scientific evidence. Ginkgo biloba’s role in improving circulation is well-documented, with a 2019 meta-analysis in Journal of Clinical Pharmacology noting its efficacy in reducing neuropathic symptoms. ALA has shown promise in clinical trials for diabetic neuropathy, with a 2018 study in Diabetes Care reporting a 30% reduction in pain scores after 12 weeks. Vitamin B12 and magnesium also have robust evidence for nerve health, with studies like the 2020 Neurology trial highlighting their role in nerve repair.

However, some ingredients, like hibiscus and gymnema sylvestre, have less direct evidence for sciatica specifically, relying more on their general anti-inflammatory and nerve-soothing properties. The proprietary Neurocalm Blend’s lack of transparency raises questions about its exact contributions, as independent evaluation is challenging. While Audizen Drops offers a promising blend, it is not a replacement for medical treatments addressing structural causes of sciatica, such as herniated discs.

User Experiences and Feedback

Since its 2025 launch, Audizen Drops has received mixed feedback. Users on the official website report reduced pain and improved mobility, with one 52-year-old user from Texas noting a “significant decrease in leg numbness” after six weeks. Another user, aged 47, reported better sleep due to less nerve discomfort. 

However, some independent reviews on platforms like Snoopviews express skepticism, with one user describing minimal effects after three weeks and concerns about unclear ingredient details. Mild side effects, such as slight digestive upset, have been reported but are rare. Audizen Drops is comparable to other premium nerve supplements. 

Multi-bottle packages offer discounts, and the 60-day refund policy mitigates risk. Critics note that the cost may be high compared to standalone magnesium or B12 supplements, though the liquid format and comprehensive formula justify the price for some.

Safety and Considerations

Audizen Drops is formulated with natural, non-GMO ingredients and is free of stimulants, making it generally safe for daily use. However, individuals on blood thinners or with chronic conditions should consult a healthcare provider, as ginkgo biloba may interact with certain medications. 

The sublingual method enhances absorption but requires consistent use for best results. Pregnant or nursing individuals should avoid use without medical advice. The exclusive online availability ensures product authenticity but may inconvenience those preferring retail purchases. Audizen Labs advises buying only from the official website to avoid counterfeits.

Audizen Drops in the Market

Audizen Drops enters a crowded market alongside supplements like SciatiEase and Nerve Renew, which also target sciatic nerve discomfort. Its liquid format and sublingual delivery set it apart, offering faster absorption than capsules. The inclusion of ginkgo biloba and ALA aligns with evidence-based trends, though proprietary blends like Neurocalm may draw scrutiny for transparency.

Compared to competitors, Audizen’s focus on both nerve health and inflammation reduction is a strength, but it’s not a cure for structural sciatica causes. It’s best suited as a complementary tool alongside physical therapy, exercise, or posture correction.

The Future of Audizen Drops

As Audizen Drops gains traction post-launch, its success will depend on consistent user outcomes and further transparency about its proprietary blend. The science behind its core ingredients is promising, and the sublingual format offers a novel delivery method. 

For those seeking a natural approach to sciatic nerve discomfort, Audizen Drops provides a compelling option, though it should be paired with medical advice for comprehensive care. 

Discover the Science Behind Audizen Drops for Hearing Clarity and Tinnitus Relief

In summary

Audizen Drops’ official launch introduces a thoughtfully crafted supplement for sciatic nerve discomfort and neuropathy. By targeting inflammation, nerve health, and pain signals, it offers a natural path to relief, backed by a 60-day guarantee. While not a standalone solution, it represents a meaningful step toward holistic nerve health support.

Project Name: Audizen Drops

Address: 382 NE 191st St PMP 82029 Miami, FL, 33179, USA

Postal Code: 33179

Media Contact

Email: support@getaudizen.com

Attachment

  • Audizen Drops

About Web3Wire
Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming.
Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.

ShareTweet1ShareSendShare2
Previous Post

Stop Holding XRP, IPI TECHNICAL LTD Launches the First ANICrypto Yield Platform with AI-Powered Daily Returns

Next Post

Arialief for Neuropathy Supplement: Official Launch of a New Hope for Sciatic Nerve Discomfort Relief

Related Posts

Kozo Keikaku Engineering Inc. & InEight Establish Partnership to Support Efficient Project Delivery in Japan

SCOTTSDALE, Ariz., April 16, 2026 (GLOBE NEWSWIRE) -- InEight and Kozo Keikaku Engineering Inc. (KKE) have announced a new partnership agreement under which KKE will become an official InEight partner supporting adoption of InEight. This partnership brings together InEight’s project information management platform and KKE’s deep engineering and consulting expertise...

Read moreDetails

Solidion Technology Reports Full Year 2025 Financial and Operating Results

DALLAS, TX, April 15, 2026 (GLOBE NEWSWIRE) -- Solidion Technology Inc. (“Solidion” or the “Company”) (Nasdaq: STI), an advanced battery technology solutions provider, today has released fiscal year 2025 Financial and Operating Results. The consolidated and combined financial statements of Solidion and additional information can be found in Solidion’s Form...

Read moreDetails

Constellation Software Inc. Announces Conference Call to Discuss First Quarter Results

TORONTO, April 15, 2026 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX:CSU) announced today it will host a first quarter conference call and live audio webcast on May 13, 2026 at 8:00 a.m. ET. The Company’s quarterly results will be disseminated via press release, and made available on the Company’s website (http://www.csisoftware.com)...

Read moreDetails

ESCO Announces Agreement to Acquire Megger Group Limited

St. Louis, April 15, 2026 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE: ESE) today announced that it has agreed to acquire the Megger Group Limited (Megger) business of TBG AG (TBG). Under the terms of the definitive agreement ESCO will acquire Megger for total consideration of $2.35 billion, consisting of...

Read moreDetails

DSS, Inc. Letter to Shareholders

ROCHESTER, N.Y., April 15, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) today issued the following letter to shareholders from the Interim CEO, Jason Grady, highlighting the Company’s operational progress, financial improvements, and strategic initiatives. Dear Fellow Shareholders, Over the past six months, our stock performance has not fully reflected...

Read moreDetails

Myseum Rebrands as Myseum.AI to Align with Full Suite of Technology and Social Media Platforms

Company developing privacy-first agentic platform for social media NEW BRUNSWICK, N.J., April 15, 2026 (GLOBE NEWSWIRE) -- Myseum, Inc. (Nasdaq: MYSE) (“Myseum” or the “Company”), a privacy-first social media and technology innovator, today announced that it is now operating under the new name Myseum.AI, Inc. effective April 15, 2026. The rebrand illuminates...

Read moreDetails

Inuvo and FreeWheel Announce Integration to Advance IntentKey’s Programmatic Decisioning

LITTLE ROCK, Ark., April 15, 2026 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence advertising technology solutions, today announced an integration with FreeWheel, a global technology platform for the advertising industry, to enhance programmatic media buying through proprietary artificial intelligence. FreeWheel’s customizable demand-side platform,...

Read moreDetails

Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026

REDWOOD CITY, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the first quarter of 2026 after the close of trading on Wednesday, April 29, 2026. Company management...

Read moreDetails

ACM Research to Release First Quarter 2026 Preliminary Revenue Range on April 27, 2026 and Full Financial Results on May 7, 2026

FREMONT, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM”) (NASDAQ: ACMR) announced today that it will release its preliminary revenue range for the first quarter of 2026 before the U.S. market open on Monday, April 27, 2026, to coincide with reporting obligations of ACM Research (Shanghai), Inc.,...

Read moreDetails

Bel Fuse Schedules First Quarter 2026 Financial Results Conference Call

WEST ORANGE, N.J., April 15, 2026 (GLOBE NEWSWIRE) -- Bel Fuse Inc. (Nasdaq: BELFA and BELFB), a global designer, manufacturer, and provider of critical electronic components, systems and solutions for customers in aerospace, defense, industrial, and data-driven markets, today announced plans to release preliminary financial results for the first quarter after...

Read moreDetails
Web3Wire NFTs - The Web3 Collective

Web3Wire, $W3W Token and .w3w tld Whitepaper

Web3Wire, $W3W Token and .w3w tld Whitepaper

Claim your space in Web3 with .w3w Domain!

Web3Wire

Trending on Web3Wire

  • A1 Data Center Transforms Former Glass Factory Into Power-Driven Innovation Campus in Millville, New Jersey

    6 shares
    Share 2 Tweet 2
  • Cross-Chain Liquidity, Meet Reality: Why 2026’s Bridge Wars Look Different

    7 shares
    Share 3 Tweet 2
  • Claw Code Launches Open-Source AI Coding Agent Framework With 72,000 GitHub Stars in First Days

    10 shares
    Share 4 Tweet 3
  • UniX AI Claims First Real-Home Deployment of Mass-Produced Humanoid Robot Panther

    6 shares
    Share 2 Tweet 2
  • Unifying Blockchain Ecosystems: 2024 Guide to Cross-Chain Interoperability

    158 shares
    Share 63 Tweet 40
Join our Web3Wire Community!

Our newsletters are only twice a month, reaching around 10000+ Blockchain Companies, 800 Web3 VCs, 600 Blockchain Journalists and Media Houses.


* We wont pass your details on to anyone else and we hate spam as much as you do. By clicking the signup button you agree to our Terms of Use and Privacy Policy.

Web3Wire Podcasts

Upcoming Events

There are currently no events.

Latest on Web3Wire

  • Arrive AI Aligns Engineering Organization to Accelerate Development, Improve Efficiency, and Support Near-Term Deployments
  • Kozo Keikaku Engineering Inc. & InEight Establish Partnership to Support Efficient Project Delivery in Japan
  • Solidion Technology Reports Full Year 2025 Financial and Operating Results
  • Constellation Software Inc. Announces Conference Call to Discuss First Quarter Results
  • Dynamic Aerospace Systems, Ticker BRQL, Reports 2025 Annual Financial Results and Strategic Direction for 2026

RSS Latest on Block3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Covo Finance: Revolutionary Crypto Leverage Trading Platform
  • WorldStrides and HEX Announce Partnership to Offer High School and University Students Innovative Courses Designed to Improve Their Outlook in the Digital Age

RSS Latest on Meta3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Thumbtack Honored as a 2023 Transform Awards Winner
  • Accenture Invests in Looking Glass to Accelerate Shift from 2D to 3D
Web3Wire

Web3Wire is your go-to source for the latest insights and updates in Web3, Metaverse, Blockchain, AI, Cryptocurrencies, DeFi, NFTs, and Gaming. We provide comprehensive coverage through news, press releases, event updates, and research articles, keeping you informed about the rapidly evolving digital world.

  • About Web3Wire
  • Founder’s Note
  • Web3Wire NFTs – The Web3 Collective
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Event Partners
  • Community Partners
  • Our Media Network
  • Media Kit
  • RSS Feeds
  • Contact Us

Crypto Coins

  • Top 10 Coins
  • Top 50 Coins
  • Top 100 Coins
  • All Coins – Marketcap
  • Crypto Coins Heatmap

Crypto Exchanges

  • Top 10 Exchanges
  • Top 50 Exchanges
  • Top 100 Exchanges
  • All Crypto Exchanges

Crypto Stocks

  • Blockchain Stocks
  • NFT Stocks
  • Metaverse Stocks
  • Artificial Intelligence Stocks

Web3Wire Whitepaper | Tokenomics

Web3 Resources

  • Top Web3 and Crypto Youtube Channels
  • Latest Crypto News
  • Latest DeFi News
  • Latest Web3 News

Blockchain Resources

  • Blockchain and Web3 Resources
  • Decentralized Finance (DeFi) – Research Reports
  • All Crypto Whitepapers

Metaverse Resources

  • AR VR and Metaverse Resources
  • Metaverse Courses
Claim your space in Web3 with .w3w!

The Klyrox Protocol | The Algorithmic Monographs

Top 50 Web3 Blogs and Websites
Web3Wire Podcast on Spotify Web3Wire Podcast on Amazon Music 
Web3Wire - Web3 and Blockchain - News, Events and Press Releases | Product Hunt
Web3Wire on Google News

Media Portfolio: Block3Wire | Meta3Wire

  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Sitemap
  • For Search Engines
  • Crypto Sitemap
  • Exchanges Sitemap

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Coins
    • Top 10 Cryptocurrencies
    • Top 50 Cryptocurrencies
    • Top 100 Cryptocurrencies
    • All Coins
  • Exchanges
    • Top 10 Cryptocurrency Exchanges
    • Top 50 Cryptocurrency Exchanges
    • Top 100 Cryptocurrency Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.